Ocular Therapeutix OCUL
NASDAQ OCUL
$6.50 -0.11 (-1.66%)
At close: Oct 23, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Non Operating Investment Income (2025)

Updated

Ocular Therapeutix (OCUL) posted Non Operating Investment Income of $29,000 for Q2 2025.

Analysis

Ocular Therapeutix (OCUL) Non Operating Investment Income (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Ocular Therapeutix 1.43 Bn -919.84 Mn 11.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 29,000.00
API Access

Ocular Therapeutix Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=OCUL&period=max&api_key=YOUR_API_KEY